PSMA PET Imaging in the Management of Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Radioligand Therapy.

Kuo PH, Calais J, Crosby M

Open source

DOI
10.1007/s11523-025-01151-7
Published
2025 Jul
Container
Targeted oncology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s11523-025-01151-7,
  title = {PSMA PET Imaging in the Management of Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Radioligand Therapy.},
  author = {Kuo PH and Calais J and Crosby M},
  year = {2025},
  journal = {Targeted oncology},
  doi = {10.1007/s11523-025-01151-7},
  url = {https://doi.org/10.1007/s11523-025-01151-7}
}

RIS

TY  - JOUR
TI  - PSMA PET Imaging in the Management of Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Radioligand Therapy.
AU  - Kuo PH
AU  - Calais J
AU  - Crosby M
PY  - 2025
JO  - Targeted oncology
DO  - 10.1007/s11523-025-01151-7
UR  - https://doi.org/10.1007/s11523-025-01151-7
ER  - 

APA

PH, K., J, C., & M, C. (2025). PSMA PET Imaging in the Management of Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Radioligand Therapy.. Targeted oncology. https://doi.org/10.1007/s11523-025-01151-7

Source records